Statement: to be eligible for the primary trial patients must be diagnosed with hormone receptor positive advanced breast cancer, and have received prior chemotherapy for this cancer.
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).